放射線・物理療法を駆使した幅広いがんの診断や治療に適応できるsurvivin標的薬剤開発

• Project/Area Number: 25K22596
• Research Category: Grant-in-Aid for Challenging Research (Exploratory)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 52:General internal medicine and related fields
• Research Institution: Kanazawa University
• Principal Investigator: 淵上 剛志 金沢大学, 薬学系, 准教授 (30432206)
• Project Period (FY): 2025-06-27 – 2027-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2026: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000); Fiscal Year 2025: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)